Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Tislelizumab and Regorafenib as First-Line Therapy for Advanced Cholangiocarcinoma
Clinical trial NCT07619937 · COMPLETED
Trial details
- NCT number
- NCT07619937
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-22
- Primary completion
- 2025-09-30
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.